216 related articles for article (PubMed ID: 26395197)
21. Extended Detection Window for Gamma-Hydroxybutyrate in the Urine of an Elderly Woman.
Berg JA; Rajendiran R; Serkland TT; Methlie CB; Hallin EI; Stokes CL
J Anal Toxicol; 2023 Apr; 47(4):e44-e47. PubMed ID: 36847150
[TBL] [Abstract][Full Text] [Related]
22. Gamma-hydroxybutyric acid (GHB) measurement by GC-MS in blood, urine and gastric contents, following an acute intoxication in Belgium.
Bodson Q; Denooz R; Serpe P; Charlier C
Acta Clin Belg; 2008; 63(3):200-8. PubMed ID: 18714853
[TBL] [Abstract][Full Text] [Related]
23. A reference range for endogenous gamma-hydroxybutyrate in urine by gas chromatography-mass spectrometry.
Crookes CE; Faulds MC; Forrest AR; Galloway JH
J Anal Toxicol; 2004; 28(8):644-9. PubMed ID: 15538958
[TBL] [Abstract][Full Text] [Related]
24. Symptoms and signs in interpreting gamma-hydroxybutyrate (GHB) intoxication - an explorative study.
Stomberg MW; Knudsen K; Stomberg H; Skärsäter I
Scand J Trauma Resusc Emerg Med; 2014 Apr; 22():27. PubMed ID: 24758357
[TBL] [Abstract][Full Text] [Related]
25. Abrupt awakening phenomenon associated with gamma-hydroxybutyrate use: a case series.
Van Sassenbroeck DK; De Neve N; De Paepe P; Belpaire FM; Verstraete AG; Calle PA; Buylaert WA
Clin Toxicol (Phila); 2007; 45(5):533-8. PubMed ID: 17503262
[TBL] [Abstract][Full Text] [Related]
26. Determination of γ-hydroxybutyrate (GHB), β-hydroxybutyrate (BHB), pregabalin, 1,4-butane-diol (1,4BD) and γ-butyrolactone (GBL) in whole blood and urine samples by UPLC-MSMS.
Dahl SR; Olsen KM; Strand DH
J Chromatogr B Analyt Technol Biomed Life Sci; 2012 Feb; 885-886():37-42. PubMed ID: 22226469
[TBL] [Abstract][Full Text] [Related]
27. Determination of gamma-hydroxybutyrate (GHB) in biological specimens by gas chromatography--mass spectrometry.
Couper FJ; Logan BK
J Anal Toxicol; 2000; 24(1):1-7. PubMed ID: 10654561
[TBL] [Abstract][Full Text] [Related]
28. Gamma-hydroxybutyrate in urine and serum: additional data supporting current cut-off recommendations.
Andresen H; Sprys N; Schmoldt A; Mueller A; Iwersen-Bergmann S
Forensic Sci Int; 2010 Jul; 200(1-3):93-9. PubMed ID: 20418032
[TBL] [Abstract][Full Text] [Related]
29. Characteristics of analytically confirmed gamma-hydroxybutyrate (GHB) positive patients in the emergency department: presentation, poly-drug use, disposition and impact on intensive care resource utilisation.
Stockham P; Partridge E; Alfred S; Boyle L; Camilleri A; Green H; Haustead D; Humphries M; Kostakis C; Mallon J
Clin Toxicol (Phila); 2023 Apr; 61(4):241-247. PubMed ID: 37129222
[TBL] [Abstract][Full Text] [Related]
30. Blood GHB concentrations and results of medical examinations in 25 car drivers in Norway.
Al-Samarraie MS; Karinen R; Mørland J; Stokke Opdal M
Eur J Clin Pharmacol; 2010 Oct; 66(10):987-98. PubMed ID: 20717656
[TBL] [Abstract][Full Text] [Related]
31. Effect of intubation for gamma-hydroxybutyric acid overdose on emergency department length of stay and hospital admission.
Dietze P; Horyniak D; Agius P; Munir V; Smit de V; Johnston J; Fry CL; Degenhardt L
Acad Emerg Med; 2014 Nov; 21(11):1226-31. PubMed ID: 25377399
[TBL] [Abstract][Full Text] [Related]
32. High-risk behaviors and hospitalizations among gamma hydroxybutyrate (GHB) users.
Kim SY; Anderson IB; Dyer JE; Barker JC; Blanc PD
Am J Drug Alcohol Abuse; 2007; 33(3):429-38. PubMed ID: 17613970
[TBL] [Abstract][Full Text] [Related]
33. Further evidence for the presence of GHB in postmortem biological fluid: implications for the interpretation of findings.
Elliott SP
J Anal Toxicol; 2004; 28(1):20-6. PubMed ID: 14987420
[TBL] [Abstract][Full Text] [Related]
34. Gamma-hydroxybutyrate serum levels and clinical syndrome after severe overdose.
Sporer KA; Chin RL; Dyer JE; Lamb R
Ann Emerg Med; 2003 Jul; 42(1):3-8. PubMed ID: 12827115
[TBL] [Abstract][Full Text] [Related]
35. Medical and legal confusion surrounding gamma-hydroxybutyrate (GHB) and its precursors gamma-butyrolactone (GBL) and 1,4-butanediol (1,4BD).
Wood DM; Warren-Gash C; Ashraf T; Greene SL; Shather Z; Trivedy C; Clarke S; Ramsey J; Holt DW; Dargan PI
QJM; 2008 Jan; 101(1):23-9. PubMed ID: 18203723
[TBL] [Abstract][Full Text] [Related]
36. Characteristics and dose-effect relationship of clinical gamma-hydroxybutyrate intoxication: A case series.
Abid M; Kietzerow J; Iwersen-Bergmann S; Schnitgerhans T; Andresen-Streichert H
J Forensic Sci; 2022 Jan; 67(1):416-427. PubMed ID: 34523720
[TBL] [Abstract][Full Text] [Related]
37. Pharmacokinetic properties of γ-hydroxybutyrate (GHB) in whole blood, serum, and urine.
Brailsford AD; Cowan DA; Kicman AT
J Anal Toxicol; 2012 Mar; 36(2):88-95. PubMed ID: 22337777
[TBL] [Abstract][Full Text] [Related]
38. [Gamma-hydroxybutyrate--an endogenous substance and a new central nervous system stimulant. Clinical aspects of acute poisoning].
Engelsen J; Christensen HR
Ugeskr Laeger; 1999 Dec; 161(50):6903-7. PubMed ID: 10643375
[TBL] [Abstract][Full Text] [Related]
39. The clinical toxicology of γ-hydroxybutyrate, γ-butyrolactone and 1,4-butanediol.
Schep LJ; Knudsen K; Slaughter RJ; Vale JA; Mégarbane B
Clin Toxicol (Phila); 2012 Jul; 50(6):458-70. PubMed ID: 22746383
[TBL] [Abstract][Full Text] [Related]
40. Physostigmine for gamma-hydroxybutyrate coma: inefficacy, adverse events, and review.
Zvosec DL; Smith SW; Litonjua R; Westfal RE
Clin Toxicol (Phila); 2007; 45(3):261-5. PubMed ID: 17453877
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
